Intl Stem Cell Corp Announces 3rd Qtr 2011 Financial Results

November 2011
Biomedical Market Newsletter;11/21/2011, Vol. 21, p789
The article reports on the 2011 third quarter financial performance of International Stem Cell Corp. (ISCO) which declares a revenue of 0.84 million dollars for the quarter. It states that increases in revenue was strongly motivated by strong sales from the initial launch of ISCO's wholly-owned subsidiary Lifeline Skin Care (LSC) and Lifeline Cell Technology (LCT). According to chief executive officer (CEO) Andrey Semechkin, sales in LSC and LCT provide the needed capital to help support growth.


Related Articles

  • International Stem Cell Discovers Method to Produce Uncontaminated Liver Cells: New Platform to Produce Various Cell Types Free From Undifferentiated, Potentially Tumorigenic, Cells.  // Biomedical Market Newsletter;6/19/2011, p758 

    The article discusses the discovery of a technology by the scientists at International Stem Cell Corp. (ISCO) which helps produce liver cells uncontaminated with undifferentiated cells. It says that the starting materials for liver cells production are pluripotent stem cells, either human...

  • International Stem Cell Corp Announces Changes to Streamline Management Team.  // Biomedical Market Newsletter;5/16/2011, p74 

    The article reports on the management changes at International Stem Cell Corp. (ISCO). It states that Brian Lundstrom has entered into a new contract which allows him to exclusively focus on therapeutic development and international partnering programs in areas outside the U.S. such as China and...

  • Intl Stem Cell Corp Completes $5 Mln Financing and Elects Jim Berglund to the Board of Directors.  // Biomedical Market Newsletter;3/14/2012, Vol. 21, p1 

    The article reports that International Stem Cell Corp. (ISCO) had obtained new capital financing of five million dollars in issued series of G Convertible Preferred Stock. It is mentioned that this financing was made by Andrey Semechkin, chief executive officer of ISCO. It further states that...

  • Cell Research Company Reports Higher Revenue. Hirsh, Lou // San Diego Business Journal;6/6/2011, Vol. 32 Issue 23, p27 

    The article reports on the financial performance of International Stem Cell Corp. wherein its revenue is 1.5 million dollars for the first quarter of 2011.

  • Revenues grow but bottomlines struggle.  // BusinessToday;2014, Issue 190, p1 

    The article discusses performance of companies in the industry sector index in Oman and also mentions that companies performance was poor in top line growth while bottom line growth was negative. It informs that Muscat Securities Market (MSM) corporate earning rose marginally by 0.8per cent to...

  • MBIA Announces $218 Million in Second-Quarter Net Income, a 50% Rise. Smith, Aaron T. // Bond Buyer;8/07/2003, Vol. 345 Issue 31694, p27 

    Presents information on the financial performance of Armonk, New York-based MBIA Inc. in 2002. Increase in second quarter net income of the company; Factors that affected the company's growth; Year-to-year decline in structured finance.

  • Aflac battered but still afloat.  // Dow Theory Forecasts;8/10/2009, Vol. 65 Issue 32, p8 

    The article reports on the financial performance of Aflac Inc., a company that offers low-cost supplemental life and health insurance in Japan and the U.S. It states that despite the effect of the economic crisis, the company has obtained a solid growth in operating profits achieving 1.20...

  • Palletline reorganisation yields return to profit.  // Motor Transport;2/1/2007, p6 

    The article focuses on the financial performance of Palletline for the year to June 30, 2006. The operating profit of the company has increased to £1.25 million. The turnover of Palletline has declined to £9.3 million in 2006. It cites the factors that contributed to the increased profit...

  • KPMG's Global Net Revenue Climbs to $16.9 Billion.  // Public Accounting Report;12/15/2006, Vol. 30 Issue 23, p4 

    The article reports on the financial performance of accounting firm KPMG for fiscal year 2006. The global revenue of KPMG climbs to $16.9 billion, good for an increase of 7.6% in U.S. dollars. The firm's 2006 fiscal year global net revenue growth rate was 9.6% in local currency ending September...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics